Rifampin Capsule
Product Images NDC 42806-799

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rifampin (NDC 42806-799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg-100ct.jpg (150mg 100ct)

150mg-100ct.jpg (150mg 100ct)
Rifampin Capsules USP 150 mg label showing a bottle containing 100 capsules. The label includes the NDC 42806-801-01 and states the product is distributed by Epic Pharma, LLC, Laurelton, NY. Instructions include storage at 20° to 25°C and warnings to keep tightly closed and out of reach of children. The product is from Korea.*
FDA Label Image

300mg-100ct.jpg (300mg 100ct)

300mg-100ct.jpg (300mg 100ct)
Rifampin Capsules, USP 300 mg oral capsules, packaged with 100 capsules per bottle. The label shows the product is distributed by Epic Pharma, LLC, Laurelton, NY. It includes storage instructions to keep the product tightly closed at controlled room temperature and out of reach of children. The NDC is 42806-799-01.*
FDA Label Image

Structure-formual.jpg (Structure Formual)

Structure-formual.jpg (Structure Formual)
Chemical structure diagram of the active ingredient rifampin, depicting its molecular arrangement with multiple hydroxyl groups, methyl groups, and a piperazine ring connected by azo and imine bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.